In order to move away from a reactive approach to risk, organisations need to improve their responses to regulation, reduce compliance costs and increase transparency.
In order to move away from a reactive approach to risk, organisations need to improve their responses to regulation, reduce compliance costs and increase transparency.
The protection of information, a need for greater transparency and strict rules and regulations are just a handful of the challenges facing the Life Sciences industry.
Many of the large pharmaceuticals have implemented comprehensive compliance programs in line with the laws and regulations that govern the industry. These programs are led from the top and should be the driving force for companies to implement a proactive approach to risk.
In order to move away from a reactive approach to risk, organisations need to improve their responses to regulation, reduce compliance costs and increase transparency.
Reputation is of vital importance to the Life Sciences industry; companies need to be demonstrating integrity and openness to both the public and stakeholders.
At Wilbury Partners we help companies identify and recruit the professionals who are leading and shaping regulatory response.
Recent assignments include:
| LONDON | BRIGHTON | HONG KONG | DUBAI |
|---|---|---|---|
1 Cornhill | Castle Square House | Level 8 | Office 2704 |
| +44 207 947 5500 | +44 1273 741300 | +852 2168 0869 | +971 4 4466371 |
| london@wpinternational.com | brighton@wpinternational.com | hongkong@wpinternational.com | dubai@wpinternational.com |